Skip to main content
. 2024 Nov 11;12(11):2284. doi: 10.3390/microorganisms12112284

Table 3.

LabMAX-3-mediated inhibition of pathogens.

Bacteria Strain Avg Zone of Inhibition ± SEM (mm)
LabMAX-3 LC * LA * EF * PA LC (ATCC 334)
Listeria monocytogenes F4244 15.83 ± 1.64 8.50 ± 0.00 19.00 ± 1.44 17.67 ± 0.72 20.67 ± 0.44 11.00 ± 0.57
Staphylococcus aureus ATCC 25923 7.33 ± 0.67 10.67 ± 0.67 9.33 ± 0.67 7.33 ± 0.67 20.67 ± 0.67 18.33 ± 0.88
Salmonella enterica serovar Typhimurium ST-1 22.67 ± 1.59 10.33 ± 0.33 15.50 ± 0.50 18.00 ± 1.26 19.83 ± 0.33 9.33 ± 2.19
Enterotoxigenic Escherichia coli F4 (K88) 19.83 ± 1.69 8.17 ± 0.88 21.17 ± 0.17 19.50 ± 1.041 22.67 ± 0.17 13.67 ± 2.73
Enterotoxigenic Escherichia coli O78:H11 6.00 ± 0.57 9.33 ± 0.67 10.00 ± 1.00 9.00 ± 0.00 11.67 ± 0.33 11.67 ± 3.28
Campylobacter jejuni ATCC 29428 15.00 10.00 10.00 13.50 22.00 NA

LabMAX-3 contains EF, LA, and LC (1:1:1); * denotes origin from LabMAX-3; EF, Enterococcus faecium; LA, Lactobacillus acidophilus; LC, Lacticaseibacillus casei; PA, Pediococcus acidilactici; and LC (ATCC 334), Lacticaseibacillus casei ATCC 334. ⁋ Indicates one trial.